Opinion

Video

Potential Complications Seen in Patients With Elevated IRP

Author(s):

Michelle Semins, MD,Seth Bechis, MD

Seth Bechis, MD, emphasizes the potential complications from elevated intra-renal pressure, such as sepsis from bacterial spread, ruptures leading to pain and difficult recovery, impaired renal function, and hemorrhage, highlighting the need for understanding these risks for better postoperative outcomes and hospital efficiency.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      Related Videos
      Hailey Frye answers a question during a Zoom video interview
      Hailey Frye discusses improvement of pain management for nephrolithiasis
      Ian Metzler, MD, on the increasing prevalence of kidney stones in women
      Ian Metzler, MD, on the increasing prevalence of kidney stones in women
      Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
      How pre-URS tamsulosin use in pediatric patients may reduce repeat procedures
      Human kidney cross section on science background. 3d render. | Image Credit: © Rasi - stock.adobe.com
      Expert discusses innovations in single-use ureteroscopes for stones
      Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
      Investigators evaluate tamsulosin use in pediatric patients
      Human kidney stones | Image Credit: © freshidea - stock.adobe.com
      Pain management disparities in kidney stones point to need for guidelines, experts say
      Perry Xu, MD, answers a question during a Zoom video interview
      Perry Xu, MD, on the potential of AI in the endourology space
      Kate H. Kraft, MD, MHPE, FACS, FAAP, answers a question during a Zoom video interview
      Kate H. Kraft, MD, discusses pre-op tamsulosin use in pediatric patients undergoing URS
      Hailey Frye answers a question during a Zoom video interview
      Study findings point to disparities in pain management for kidney stones
      Christina Ching, MD, on overcoming barriers to follow-up after pediatric stone surgery
      Christina Ching, MD, on overcoming barriers to follow-up after pediatric stone surgery
      Related Content
      “Go big or go small”: Current and emerging tools in kidney stone management
      April 11th 2025

      “Go big or go small”: Current and emerging tools in kidney stone management

      Brian R. Stork, MD Hannah Clarke
      “The technology in the field of stone management is exciting, and I think it offers patients a lot more options than what they've had in the past,” says Brian Stork, MD.
      Why kidney stones will become more prevalent over time
      February 17th 2022

      Why kidney stones will become more prevalent over time

      Urology Times staff
      “The prevalence of kidney stones has increased over 80% over the last 30 years, and the epidemiology has changed such that it's beginning at a younger age now,” says Gregory Tasian, MD, MSc, MSCE.
      FDA reports Urgent Device Field Correction notice for CVAC Aspiration System
      March 21st 2025

      FDA reports Urgent Device Field Correction notice for CVAC Aspiration System

      Hannah Clarke
      Calyxo has identified a new risk of injury when the CVAC System is used in patients with high viscosity fluid in their kidneys at the start of the procedure.
      Dr. Krambeck investigates efficacy of Trilogy and ShockPulse-SE lithotripters
      September 9th 2021

      Dr. Krambeck investigates efficacy of Trilogy and ShockPulse-SE lithotripters

      Urology Times staff
      “You have tradeoffs with every device that you use,” says Amy E. Krambeck, MD.
      Kidney stone prevalence is increasing in women, study findings show
      March 17th 2025

      Kidney stone prevalence is increasing in women, study findings show

      Hannah Clarke
      The overall prevalence of kidney stones remained stable, with a notable increase observed among women.
      FDA updates in urology: February 2025
      March 3rd 2025

      FDA updates in urology: February 2025

      Hannah Clarke
      A recap of the FDA submissions and regulatory decisions in urology from February 2025.
      © 2025 MJH Life Sciences

      All rights reserved.